|
US - In November ####, the board of Genentech Inc, a manufacturer of pharmaceuticals and a majority owned unit of Roche Holding AG, authorized the repurchase of up to $### mil of the company's common stock outstanding in open market…
|
| Credit & Investment Research |
|
|